Portolan Capital Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,699,918
Closed -$30.7M 160
2024
Q3
$30.7M Buy
1,699,918
+569,829
+50% +$10.3M 2.23% 9
2024
Q2
$11.6M Buy
+1,130,089
New +$11.6M 0.96% 39